Zaloga G P, Chernow B, Smallridge R C, Zajtchuk R, Hall-Boyer K, Hargraves R, Lake C R, Burman K D
Ann Surg. 1985 Apr;201(4):456-64. doi: 10.1097/00000658-198504000-00010.
Thyroid hormone alterations (known as the "sick-euthyroid syndrome") are common following major surgery, but the time course for appearance and recovery from these alterations has not previously been longitudinally studied in a large group of surgical patients. The authors prospectively studied 59 patients undergoing major surgery (coronary artery bypass grafting, pneumonectomy, or subtotal colectomy). Compared with preoperative values, the mean serum T4, T3, free T3, and TSH concentrations decreased significantly (p less than 0.05) following surgery. Serum reverse T3 and T3 resin uptake index increased, while free T4 levels remained unchanged. These changes were seen within 6 hours of surgery and normalized by 1 week after surgery. Although the serum TSH response to TRH was normal before and after surgery in 56 of the 59 patients, the maximal TRH-induced increase in serum TSH and the integrated serum TSH response to TRH were suppressed in the early perioperative period. This postoperative TSH suppression correlated with elevated postoperative plasma dopamine concentrations (r = 0.57, p less than 0.05). Three patients with compensated primary hypothyroidism were detected in the study and represent the first documentation of serial thyroid hormone and TSH levels in hypothyroid patients undergoing major surgery. These patients had similar changes in thyroid hormone values compared with euthyroid patients. The serum TSH response to TRH was suppressed into the normal range in two of these patients on the day following surgery. The authors conclude that the sick-euthyroid syndrome occurs within a few hours of major surgery and remits with convalescence. Postoperative decreases in serum TSH may mask the diagnosis of hypothyroidism. Surgical consultants should be aware of these rapid postoperative changes so that thyroid function tests are properly interpreted in patients who have undergone major surgery.
甲状腺激素改变(即“病态甲状腺综合征”)在大手术后很常见,但此前尚未对一大群外科手术患者这些改变的出现及恢复的时间进程进行纵向研究。作者前瞻性地研究了59例接受大手术(冠状动脉搭桥术、肺切除术或结肠次全切除术)的患者。与术前值相比,术后血清总甲状腺素(T4)、三碘甲状腺原氨酸(T3)、游离T3和促甲状腺激素(TSH)浓度显著降低(p<0.05)。血清反T3和T3树脂摄取指数升高,而游离T4水平保持不变。这些变化在术后6小时内出现,并在术后1周恢复正常。虽然59例患者中有56例术前和术后血清TSH对促甲状腺激素释放激素(TRH)的反应正常,但围手术期早期TRH诱导的血清TSH最大升高及血清TSH对TRH的综合反应受到抑制。术后TSH抑制与术后血浆多巴胺浓度升高相关(r=0.57,p<0.05)。研究中检测到3例代偿性原发性甲状腺功能减退患者,这是首次记录接受大手术的甲状腺功能减退患者的系列甲状腺激素和TSH水平。与甲状腺功能正常的患者相比,这些患者的甲状腺激素值有类似变化。其中2例患者术后第1天血清TSH对TRH的反应被抑制到正常范围内。作者得出结论,病态甲状腺综合征在大手术后数小时内出现,并随康复而缓解。术后血清TSH降低可能掩盖甲状腺功能减退的诊断。外科会诊医生应了解这些术后快速变化,以便对接受大手术的患者正确解读甲状腺功能检查结果。